REPRESENTATIVES' WARRANT AGREEMENT Dated as of , 1997 ------------Warrant Agreement • May 1st, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
Exhibit 1 [Form of Underwriting Agreement]Underwriting Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
500,000 UnitsUnderwriting Agreement • May 1st, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Colorado
ANDWarrant Agreement • May 1st, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Delaware
WITNESSETHPatent License Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
Exhibit 10.17 FINANCIAL ADVISORY AGREEMENT This Agreement is made and entered into as of March __, 1997, between First United Equities Corporation ("First United") and Apollo BioPharmaceutics, Inc., a Delaware corporation, (the "Company"). In...Financial Advisory Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
INDEMNIFICATION AGREEMENT [NAME OF DIRECTOR] This Agreement dated _______________ is between Apollo Genetics, Inc. (the "Company"), a Delaware corporation, and [NAME OF DIRECTOR] (the "Director"), who is a director of the Company. Its purpose is to...Indemnification Agreement • December 24th, 1996 • Apollo Biopharmaceutics Inc • Massachusetts
EXHIBIT 3.3 REGISTRATION RIGHTS AGREEMENT This Agreement is made as of the 18th day of December, 1996.Registration Rights Agreement • December 24th, 1996 • Apollo Biopharmaceutics Inc • Massachusetts
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
CORPORATE RESEARCH AGREEMENT TO ACCOMPANY LICENSE AGREEMENTParticipation Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Florida
ROYALTY PURCHASE AGREEMENT BETWEEN NEUROSCIENCE PARTNERS LIMITED PARTNERSHIP BY ITS GENERAL PARTNER, MDS ASSOCIES-NEUROSCIENCE INC. - AND - APOLLO GENETICS, INC. DECEMBER 18, 1996Royalty Purchase Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Massachusetts
NEURON LOSS PROTECTION TECHNOLOGY LICENSE AGREEMENTNeuron Loss Protection Technology License Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
APOLLO Genetics May 15, 1996 Robert J. Leonard 37 Atlantic Avenue Swampscott, MA 01907 Dear Robert: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you, initially in a consulting capacity, as Vice...Apollo Biopharmaceutics Inc • March 17th, 1997 • Pharmaceutical preparations
APOLLO Genetics May 15, 1996 Robert J. Leonard 37 Atlantic Avenue Swampscott, MA 01907 Dear Robert: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you, initially in a consulting capacity, as Vice President of Business Development, subject to the supervision of, and to have such authority as is delegated to you by, the Chief Executive Officer and the Board of Directors of the Company. You shall devote your business time, attention and energies to the business and interests of the Company. In consideration of the services to be rendered by you hereunder, the Company shall pay you an annual salary of $100,000, payable in accordance with the Company's usual payment practices (the "Base Salary"). The first seven months of your employment shall be on a half-time basis (salary to be adjusted on a pro-rata basis) and employment following that on a full-time basis. Your compensation package shall be reviewed annually. Your employment by the
LICENSE, RESEARCH AND COLLABORATION AGREEMENT This License, Research and Collaboration Agreement is entered into as of the 13th day of December, 1996 by and between Apollo Genetics, Inc., a Delaware corporation ("Apollo"), and Endocon, Inc., a...License, Research and Collaboration Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Massachusetts
NONEXCLUSIVE SUBLICENSE AGREEMENT This Nonexclusive Sublicense Agreement (this "Agreement") is made as of November 5, 1996, by and between Apollo Genetics, Inc., a corporation organized and existing under the laws of Delaware ("Apollo"), and Cephalon,...Nonexclusive Sublicense Agreement • December 24th, 1996 • Apollo Biopharmaceutics Inc • Massachusetts
or conflict of law provision or rule whether of the State of Colorado or any other jurisdiction that would cause the application of the laws of any jurisdiction other than the State of Colorado. The parties agree to the exclusive jurisdiction of the...Apollo Biopharmaceutics Inc • May 1st, 1997 • Pharmaceutical preparations • Colorado
EMPLOYMENT AGREEMENTEmployment Agreement • December 24th, 1996 • Apollo Biopharmaceutics Inc • Massachusetts
APOLLO Genetics John J. Curry 859 Washington Street Franklin, MA 02038 November 10, 1996 Dear John: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you in an executive capacity, as Vice President...Apollo Biopharmaceutics Inc • March 17th, 1997 • Pharmaceutical preparations
APOLLO Genetics John J. Curry 859 Washington Street Franklin, MA 02038 November 10, 1996 Dear John: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you in an executive capacity, as Vice President of Finance and Administration & Chief Financial Officer, subject to the supervision of, and to have such authority as is delegated to you by, the Chief Executive Officer. You shall devote your entire business time, attention and energies to the business and interests of the Company. In consideration of the services to be rendered by you hereunder, the Company shall pay you an annual salary of $80,000, payable in accordance with the Company's usual payment practices (the "Base Salary"). The first month of your employment shall be on a half-time basis and employment following that on a full-time basis. Subject to the approval of the Compensation Committee of the Board, I am recommending that you also receive incentive stock options (the "Opti
